On the public citation graph

Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years

0 signed · 428 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/1529-0131(199801)41:1<58::aid-art8>3.0.co;2-gopenalex-snapshot
Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors
inferredcites →https://doi.org/10.1002/art.1780270401openalex-snapshot
Evaluation of Diagnostic Criteria for Ankylosing Spondylitis
inferredcites →https://doi.org/10.1002/art.1780380407openalex-snapshot
Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis
inferredcites →https://doi.org/10.1002/art.20217openalex-snapshot
Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti–tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: A randomized, placebo‐controlled, 52‐week trial
inferredcites →https://doi.org/10.1002/art.20335openalex-snapshot
Etanercept treatment of psoriatic arthritis: Safety, efficacy, and effect on disease progression
inferredcites →https://doi.org/10.1002/art.20446openalex-snapshot
What is the most appropriate radiologic scoring method for ankylosing spondylitis?
inferredcites →https://doi.org/10.1002/art.21054openalex-snapshot
Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: A randomized clinical trial
inferredcites →https://doi.org/10.1002/art.21133openalex-snapshot
How should treatment effect on spinal radiographic progression in patients with ankylosing spondylitis be measured?
inferredcites →https://doi.org/10.1002/art.21655openalex-snapshot
Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: Two‐year clinical and radiographic results from the TEMPO study, a double‐blind, randomized trial
inferredcites →https://doi.org/10.1002/art.21897openalex-snapshot
Noggin haploinsufficiency differentially affects tissue responses in destructive and remodeling arthritis
inferredcites →https://doi.org/10.1002/art.21913openalex-snapshot
Efficacy and safety of adalimumab in patients with ankylosing spondylitis: Results of a multicenter, randomized, double‐blind, placebo‐controlled trial
inferredcites →https://doi.org/10.1002/art.22372openalex-snapshot
Evidence for uncoupling of inflammation and joint remodeling in a mouse model of spondylarthritis
inferredcites →https://doi.org/10.1002/art.22589openalex-snapshot
Serum matrix metalloproteinase 3 is an independent predictor of structural damage progression in patients with ankylosing spondylitis
inferredcites →https://doi.org/10.1002/art.22818openalex-snapshot
Low molecular weight isoforms of the aggrecanases are responsible for the cytokine‐induced proteolysis of aggrecan in a porcine chondrocyte culture system
inferredcites →https://doi.org/10.1002/art.23260openalex-snapshot
Critical appraisal of assessment of structural damage in ankylosing spondylitis: Implications for treatment outcomes
inferredcites →https://doi.org/10.1002/art.23471openalex-snapshot
Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept
inferredcites →https://doi.org/10.1002/art.23901openalex-snapshot
Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis
inferredcites →https://doi.org/10.1002/art.24132openalex-snapshot
Inflammatory lesions of the spine on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis: Evidence of a relationship between inflammation and new bone formation
inferredcites →https://doi.org/10.1093/rheumatology/kem166openalex-snapshot
Radiographic progression in patients with ankylosing spondylitis after 4 yrs of treatment with the anti-TNF- antibody infliximab
inferredcites →https://doi.org/10.1136/ard.2004.020503openalex-snapshot
Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system
inferredcites →https://doi.org/10.1136/ard.2004.029710openalex-snapshot
A longitudinal study on an autoimmune murine model of ankylosing spondylitis
inferredcites →https://doi.org/10.1136/ard.2004.029728openalex-snapshot
Association between radiographic damage of the spine and spinal mobility for individual patients with ankylosing spondylitis: can assessment of spinal mobility be a proxy for radiographic evaluation?
inferredcites →https://doi.org/10.1136/ard.2005.045658openalex-snapshot
The Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT): results of radiographic analyses after 1 year
inferredcites →https://doi.org/10.1136/ard.2007.087270openalex-snapshot
Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS trial
inferredcites →https://doi.org/10.1172/jci0215582openalex-snapshot
Osteoclasts are essential for TNF-α–mediated joint destruction
inferredcites →https://doi.org/10.1172/jci11176openalex-snapshot
TNF-α induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand
inferredcites →https://doi.org/10.1172/jci15582openalex-snapshot
Osteoclasts are essential for TNF-α–mediated joint destruction
inferredcites →https://doi.org/10.1172/jci16069openalex-snapshot
Mechanisms of TNF-α– and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis
inferredcites →https://doi.org/10.1186/ar2496openalex-snapshot
The relationship between inflammation and new bone formation in patients with ankylosing spondylitis
inferredcites →https://doi.org/10.1186/ar2565openalex-snapshot
What do biomarkers tell us about the pathogenesis of ankylosing spondylitis?

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.1002/14651858.cd006977.pub2openalex-snapshot
Self management programme for ankylosing spondylitis
inferred← citeshttps://doi.org/10.1002/14651858.cd010952openalex-snapshot
Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis)
inferred← citeshttps://doi.org/10.1002/14651858.cd010952.pub2openalex-snapshot
Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis)
inferred← citeshttps://doi.org/10.1002/9783527692156.ch42openalex-snapshot
Rheumatoid Arthritis and Other Inflammatory Articular Diseases
inferred← citeshttps://doi.org/10.1002/acr.22083openalex-snapshot
Development and Validation of the Spondyloarthritis Radiography Module for Calibration of Readers Using the Modified Stoke Ankylosing Spondylitis Spine Score
inferred← citeshttps://doi.org/10.1002/acr.22308openalex-snapshot
Reliability of Radiographic Scoring Methods in Axial Psoriatic Arthritis
inferred← citeshttps://doi.org/10.1002/acr.23097openalex-snapshot
Reduction in Spinal Radiographic Progression in Ankylosing Spondylitis Patients Receiving Prolonged Treatment With Tumor Necrosis Factor Inhibitors
inferred← citeshttps://doi.org/10.1002/acr.24104openalex-snapshot
Factors Predictive of Radiographic Progression in Ankylosing Spondylitis
inferred← citeshttps://doi.org/10.1002/art.30393openalex-snapshot
Focal fat lesions at vertebral corners on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis
inferred← citeshttps://doi.org/10.1002/art.30627openalex-snapshot
Radiographic progression is associated with resolution of systemic inflammation in patients with axial spondylarthritis treated with tumor necrosis factor α inhibitors: A study of radiographic progression, inflammation on magnetic resonance imaging, and c
inferred← citeshttps://doi.org/10.1002/art.33430openalex-snapshot
Radiographic severity of ankylosing spondylitis is associated with polymorphism of the large multifunctional peptidase 2 gene in the Spondyloarthritis Research Consortium of Canada cohort
inferred← citeshttps://doi.org/10.1002/art.33447openalex-snapshot
A comparison of new bone formation in patients with ankylosing spondylitis and patients with diffuse idiopathic skeletal hyperostosis: A retrospective cohort study over six years
inferred← citeshttps://doi.org/10.1002/art.33465openalex-snapshot
Baseline radiographic damage, elevated acute‐phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis
inferred← citeshttps://doi.org/10.1002/art.34441openalex-snapshot
Independent development of inflammation and new bone formation in ankylosing spondylitis
inferred← citeshttps://doi.org/10.1002/art.34442openalex-snapshot
Motion for debate: The development of ankylosis in ankylosing spondylitis is largely dependent on inflammation
inferred← citeshttps://doi.org/10.1002/art.37703openalex-snapshot
Changing paradigms in spondylarthritis: The myofibroblast signature
inferred← citeshttps://doi.org/10.1002/art.37704openalex-snapshot
Disease‐specific and inflammation‐independent stromal alterations in spondylarthritis synovitis
inferred← citeshttps://doi.org/10.1002/art.38068openalex-snapshot
Editorial: Anti–Tumor Necrosis Factor and New Bone Formation in Ankylosing Spondylitis: The Controversy Continues
inferred← citeshttps://doi.org/10.1002/art.38070openalex-snapshot
The Impact of Tumor Necrosis Factor α Inhibitors on Radiographic Progression in Ankylosing Spondylitis
inferred← citeshttps://doi.org/10.1002/art.38384openalex-snapshot
US Trends in Rates of Arthroplasty for Inflammatory Arthritis Including Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, and Spondyloarthritis
inferred← citeshttps://doi.org/10.1002/art.39766openalex-snapshot
Clinical and Imaging Signs of Spondyloarthritis in First‐Degree Relatives of HLA–B27–Positive Ankylosing Spondylitis Patients: The Pre‐Spondyloarthritis (Pre‐SpA) Cohort Study
inferred← citeshttps://doi.org/10.1002/art.40175openalex-snapshot
Macrophage Migration Inhibitory Factor Induces Inflammation and Predicts Spinal Progression in Ankylosing Spondylitis
inferred← citeshttps://doi.org/10.1002/art.40468openalex-snapshot
Inflammation Intensity–Dependent Expression of Osteoinductive Wnt Proteins Is Critical for Ectopic New Bone Formation in Ankylosing Spondylitis
inferred← citeshttps://doi.org/10.1002/art.40661openalex-snapshot
Impact of Tumor Necrosis Factor Inhibitor Versus Nonsteroidal Antiinflammatory Drug Treatment on Radiographic Progression in Early Ankylosing Spondylitis: Its Relationship to Inflammation Control During Treatment
inferred← citeshttps://doi.org/10.1002/art.40750openalex-snapshot
Sacroiliac Joint Ankylosis in Young Spondyloarthritis Patients Receiving Biologic Therapy: Observation of Serial Magnetic Resonance Imaging Scans
inferred← citeshttps://doi.org/10.1002/art.41164openalex-snapshot
Nonsteroidal Antiinflammatory Drugs as Potential Disease‐Modifying Medications in Axial Spondyloarthritis
inferred← citeshttps://doi.org/10.1002/art.41206openalex-snapshot
Effect of Therapy on Radiographic Progression in Axial Spondyloarthritis: A Systematic Review and Meta‐Analysis
inferred← citeshttps://doi.org/10.1002/jmri.24762openalex-snapshot
Utilizing MR enterography for detection of sacroiliitis in patients with inflammatory bowel disease
inferred← citeshttps://doi.org/10.1007/978-1-4614-5366-6_10openalex-snapshot
The Relationship Between Inflammation, Destruction, and Remodeling in Chronic Joint Diseases
inferred← citeshttps://doi.org/10.1007/978-3-030-23022-7_1openalex-snapshot
Immunological Basis of Inflammatory Arthritides
inferred← citeshttps://doi.org/10.1007/978-3-030-80699-6_15openalex-snapshot
Ankylosing Spondylitis
inferred← citeshttps://doi.org/10.1007/978-3-319-12508-4_5openalex-snapshot
Quantitative Monitoring of Bone Formation in Ankylosing Spondylitis Using Computed Tomography
inferred← citeshttps://doi.org/10.1007/978-3-319-19530-8_13openalex-snapshot
Mechanisms of Bone Remodelling in Psoriatic Arthritis
inferred← citeshttps://doi.org/10.1007/978-3-319-34238-2_8openalex-snapshot
Rheumatoid Arthritis and Spondyloarthritis
inferred← citeshttps://doi.org/10.1007/978-3-7091-0520-7_8openalex-snapshot
Rheumatoid Arthritis and Ankylosing Spondylitis
inferred← citeshttps://doi.org/10.1007/s00223-017-0237-8openalex-snapshot
Tumor Necrosis Factor Alpha Overexpression Induces Mainly Osteoclastogenesis at the Vertebral Site
inferred← citeshttps://doi.org/10.1007/s00223-017-0356-2openalex-snapshot
Bone Disease in Axial Spondyloarthritis
inferred← citeshttps://doi.org/10.1007/s00223-021-00933-1openalex-snapshot
Bone Involvement in Patients with Spondyloarthropathies
inferred← citeshttps://doi.org/10.1007/s00228-014-1706-xopenalex-snapshot
Impact of biological therapy on spondyloarthritis
inferred← citeshttps://doi.org/10.1007/s00281-014-0442-8openalex-snapshot
Mechanisms of tissue damage in arthritis
inferred← citeshttps://doi.org/10.1007/s00296-015-3387-xopenalex-snapshot
Focal bone involvement in inflammatory arthritis: the role of IL17
inferred← citeshttps://doi.org/10.1007/s00296-016-3635-8openalex-snapshot
Should axial spondyloarthritis without radiographic changes be treated with anti-TNF agents?
inferred← citeshttps://doi.org/10.1007/s00296-017-3660-2openalex-snapshot
Baseline increased 18F-fluoride uptake lesions at vertebral corners on positron emission tomography predict new syndesmophyte development in ankylosing spondylitis: a 2-year longitudinal study
inferred← citeshttps://doi.org/10.1007/s00296-021-04807-5openalex-snapshot
Evaluation of the early cervical structural change in patients with non-radiographic axial spondyloarthropathy
inferred← citeshttps://doi.org/10.1007/s00296-021-05024-wopenalex-snapshot
Tumor necrosis factor inhibitor (TNFi) persistence and reasons for discontinuation in a predominantly male cohort with axial spondyloarthritis
inferred← citeshttps://doi.org/10.1007/s00393-011-0895-2openalex-snapshot
Frühtherapie bei axialer Spondyloarthritis und Relevanz der radiologischen Progression
inferred← citeshttps://doi.org/10.1007/s00393-012-1089-2openalex-snapshot
ASAS-Empfehlungen zur Anwendung von TNF-Blockern bei Patienten mit axialer Spondyloarthritis
inferred← citeshttps://doi.org/10.1007/s00393-014-1428-6openalex-snapshot
DGRh-S3-Leitlinie Axiale Spondyloarthritis inklusive Morbus Bechterew und Frühformen
inferred← citeshttps://doi.org/10.1007/s00393-014-1443-7openalex-snapshot
DGRh-S3-Leitlinie Axiale Spondyloarthritis inklusive Morbus Bechterew und Frühformen
inferred← citeshttps://doi.org/10.1007/s00586-019-05912-7openalex-snapshot
Radiologic parameters of ankylosing spondylitis patients treated with anti-TNF-α versus nonsteroidal anti-inflammatory drugs and sulfasalazine
inferred← citeshttps://doi.org/10.1007/s10067-013-2278-3openalex-snapshot
Management of hip involvement in ankylosing spondylitis
inferred← citeshttps://doi.org/10.1007/s10067-015-2939-5openalex-snapshot
Performance of ultrasound to monitor Achilles enthesitis in patients with ankylosing spondylitis during TNF-a antagonist therapy
inferred← citeshttps://doi.org/10.1007/s10067-015-2956-4openalex-snapshot
Ankylosis in ankylosing spondylitis: current concepts
inferred← citeshttps://doi.org/10.1007/s10067-016-3264-3openalex-snapshot
Physical activity in axial spondyloarthritis—tails from bench to bedside
inferred← citeshttps://doi.org/10.1007/s10067-022-06070-wopenalex-snapshot
The impact of anti-TNF treatment on Wnt signaling, noggin, and cytokine levels in axial spondyloarthritis
inferred← citeshttps://doi.org/10.1007/s10067-026-08254-0openalex-snapshot
Patient and physician global assessments capture distinct clinical domains in axial spondyloarthritis
inferred← citeshttps://doi.org/10.1007/s10165-013-0891-2openalex-snapshot
Elevated miR-29a expression is not correlated with disease activity index in PBMCs of patients with ankylosing spondylitis
inferred← citeshttps://doi.org/10.1007/s10238-023-01102-4openalex-snapshot
Frontiers of ankylosing spondylitis research: an analysis from the top 100 most influential articles in the field
inferred← citeshttps://doi.org/10.1007/s10354-014-0338-1openalex-snapshot
Anti-TNFs in axial spondyloarthritis
inferred← citeshttps://doi.org/10.1007/s11606-021-07241-2openalex-snapshot
Ankylosing Spondylitis and the Risk of Hip Fractures: a Matched Cohort Study
inferred← citeshttps://doi.org/10.1007/s11914-013-0183-yopenalex-snapshot
Impact of Inflammation on the Osteoblast in Rheumatic Diseases
inferred← citeshttps://doi.org/10.1007/s11926-010-0125-yopenalex-snapshot
Update on Biologic Therapy in the Management of Axial Spondyloarthritis
inferred← citeshttps://doi.org/10.1007/s11926-011-0202-xopenalex-snapshot
Pathophysiology of Spondyloarthritis
inferred← citeshttps://doi.org/10.1007/s11926-012-0282-2openalex-snapshot
Biologic Therapies for Spondyloarthritis: What Is New?
inferred← citeshttps://doi.org/10.1007/s11926-014-0466-zopenalex-snapshot
Enthesitis-Related Arthritis: Time to Re-define?
inferred← citeshttps://doi.org/10.1007/s11926-017-0639-7openalex-snapshot
Structural Disease Progression in Axial Spondyloarthritis: Still a Cause for Concern?
inferred← citeshttps://doi.org/10.1007/s11926-017-0644-xopenalex-snapshot
The Paradox of Bone Formation and Bone Loss in Ankylosing Spondylitis: Evolving New Concepts of Bone Formation and Future Trends in Management
inferred← citeshttps://doi.org/10.1007/s11926-018-0759-8openalex-snapshot
Better Quantification of Syndesmophyte Growth in Axial Spondyloarthritis
inferred← citeshttps://doi.org/10.1007/s11926-018-0795-4openalex-snapshot
Radiographic Progression in Ankylosing Spondylitis: From Prognostication to Disease Modification
inferred← citeshttps://doi.org/10.1007/s11926-019-0844-7openalex-snapshot
Current Unmet Needs in Spondyloarthritis
inferred← citeshttps://doi.org/10.1007/s12016-015-8515-6openalex-snapshot
Bone as a Target Organ in Rheumatic Disease: Impact on Osteoclasts and Osteoblasts
inferred← citeshttps://doi.org/10.1007/s12325-024-03098-zopenalex-snapshot
Efficacy, Safety, and Immunogenicity of SDZ-ADL, an Adalimumab Biosimilar, in Biologic-Naïve and Switched Patients with Immune-Mediated Inflammatory Diseases: A Literature Review
inferred← citeshttps://doi.org/10.1007/s40261-020-00886-7openalex-snapshot
Comparison of the Effects of Secukinumab and Adalimumab Biosimilar on Radiographic Progression in Patients with Ankylosing Spondylitis: Design of a Randomized, Phase IIIb Study (SURPASS)
inferred← citeshttps://doi.org/10.1007/s40265-018-0971-xopenalex-snapshot
Beyond the TNF-α Inhibitors: New and Emerging Targeted Therapies for Patients with Axial Spondyloarthritis and their Relation to Pathophysiology
inferred← citeshttps://doi.org/10.1007/s40272-020-00416-0openalex-snapshot
Treatment of Juvenile Spondyloarthritis: Where We Stand
inferred← citeshttps://doi.org/10.1007/s40744-023-00627-0openalex-snapshot
The Role of Early Treatment in the Management of Axial Spondyloarthritis: Challenges and Opportunities
inferred← citeshttps://doi.org/10.1016/b978-0-12-384929-8.00038-1openalex-snapshot
Spondyloarthritides
inferred← citeshttps://doi.org/10.1016/b978-0-12-812102-3.00036-1openalex-snapshot
Spondyloarthritides
inferred← citeshttps://doi.org/10.1016/b978-0-323-09138-1.00063-2openalex-snapshot
Tumor necrosis factor–blocking therapies
inferred← citeshttps://doi.org/10.1016/b978-0-323-56800-5.00008-4openalex-snapshot
Bone Pathophysiology in Axial Spondyloarthritis
inferred← citeshttps://doi.org/10.1016/b978-0-323-56800-5.00010-2openalex-snapshot
Imaging in Axial Spondyloarthritis
inferred← citeshttps://doi.org/10.1016/b978-1-4377-1738-9.00074-8openalex-snapshot
Pathogenesis of Ankylosing Spondylitis and Reactive Arthritis
inferred← citeshttps://doi.org/10.1016/b978-2-294-71924-0.00004-8openalex-snapshot
Spondyloarthrites
inferred← citeshttps://doi.org/10.1016/b978-2-294-77859-9.00004-9openalex-snapshot
Les traitements de fond des spondyloarthrites axiales ont-ils un effet structural ?
inferred← citeshttps://doi.org/10.1016/b978-2-294-78249-7.00004-7openalex-snapshot
Progression structurale des spondyloarthrites
inferred← citeshttps://doi.org/10.1016/j.ard.2026.03.023openalex-snapshot
Transmembrane TNF-α signalling of macrophages drives pathological osteogenesis in radiographic axial spondyloarthritis
inferred← citeshttps://doi.org/10.1016/j.autrev.2017.01.014openalex-snapshot
Effects of targeted therapies on the bone in arthritides
inferred← citeshttps://doi.org/10.1016/j.autrev.2017.07.012openalex-snapshot
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?
inferred← citeshttps://doi.org/10.1016/j.autrev.2018.07.002openalex-snapshot
The profiling of axial spondyloarthritis patient candidate to a biologic therapy: Consensus from a Delphi-panel of Italian experts
inferred← citeshttps://doi.org/10.1016/j.autrev.2024.103638openalex-snapshot
Treatment strategies for Spondyloarthritis: Implementation of precision medicine – Or “one size fits all” concept?
inferred← citeshttps://doi.org/10.1016/j.autrev.2026.104076openalex-snapshot
SpA in animal models: Unraveling the duality of inflammation and bone formation
inferred← citeshttps://doi.org/10.1016/j.bbrc.2026.153608openalex-snapshot
Chondrocyte proliferation without inflammation underlies botulinum toxin–induced mandibular enthesis bone hypertrophy in rats
inferred← citeshttps://doi.org/10.1016/j.berh.2010.01.005openalex-snapshot
Can we stop progression of ankylosing spondylitis?
inferred← citeshttps://doi.org/10.1016/j.berh.2010.05.005openalex-snapshot
Are current available therapies disease-modifying in spondyloarthritis?
inferred← citeshttps://doi.org/10.1016/j.berh.2011.11.006openalex-snapshot
Spondyloarthritides
inferred← citeshttps://doi.org/10.1016/j.berh.2012.10.003openalex-snapshot
Controversies in conventional radiography in spondyloarthritis
inferred← citeshttps://doi.org/10.1016/j.berh.2014.03.005openalex-snapshot
Therapeutic advancements in juvenile idiopathic arthritis
inferred← citeshttps://doi.org/10.1016/j.berh.2014.10.008openalex-snapshot
Bone formation in axial spondyloarthritis
inferred← citeshttps://doi.org/10.1016/j.berh.2015.04.002openalex-snapshot
The impact of ankylosing spondylitis/axial spondyloarthritis on work productivity
inferred← citeshttps://doi.org/10.1016/j.berh.2018.07.007openalex-snapshot
Evolving concepts of new bone formation in axial spondyloarthritis: Insights from animal models and human studies
inferred← citeshttps://doi.org/10.1016/j.berh.2018.10.006openalex-snapshot
Update on the epidemiology, risk factors, and disease outcomes of axial spondyloarthritis
inferred← citeshttps://doi.org/10.1016/j.berh.2019.02.007openalex-snapshot
Disease modification in axial spondyloarthritis
inferred← citeshttps://doi.org/10.1016/j.berh.2019.07.001openalex-snapshot
How to investigate: Early axial spondyloarthritis
inferred← citeshttps://doi.org/10.1016/j.bionut.2012.10.013openalex-snapshot
Osteoclasts from peripheral blood mononuclear cells culture of ankylosing spondylitis subjects are resistant to apoptosis
inferred← citeshttps://doi.org/10.1016/j.biopha.2018.10.137openalex-snapshot
Ankylosing spondylitis and mesenchymal stromal/stem cell therapy: a new therapeutic approach
inferred← citeshttps://doi.org/10.1016/j.cyto.2016.07.015openalex-snapshot
Anti cytokine therapy in chronic inflammatory arthritis
inferred← citeshttps://doi.org/10.1016/j.injr.2013.11.008openalex-snapshot
Outcome assessment in axial spondyloarthritis-imaging techniques, their relation to outcomes and their use in clinical trials
inferred← citeshttps://doi.org/10.1016/j.isci.2021.102791openalex-snapshot
ATF6 aggravates angiogenesis-osteogenesis coupling during ankylosing spondylitis by mediating FGF2 expression in chondrocytes
inferred← citeshttps://doi.org/10.1016/j.jbspin.2011.09.008openalex-snapshot
Insights into the pathophysiology of ankylosing spondylitis: Contributions from animal models
inferred← citeshttps://doi.org/10.1016/j.jbspin.2013.01.003openalex-snapshot
Evaluation of spondylarthritis activity by patients and physicians: ASDAS, BASDAI, PASS, and flares in 200 patients
inferred← citeshttps://doi.org/10.1016/j.jbspin.2013.02.004openalex-snapshot
New bone formation in axial spondyloarthritis
inferred← citeshttps://doi.org/10.1016/j.jbspin.2014.05.004openalex-snapshot
Elemene, the essential oil of Curcuma wenyujin, inhibits osteogenic differentiation in ankylosing spondylitis
inferred← citeshttps://doi.org/10.1016/j.jbspin.2015.02.018openalex-snapshot
Enthesitis: The clue to the pathogenesis of spondyloarthritis?
inferred← citeshttps://doi.org/10.1016/j.jbspin.2015.06.013openalex-snapshot
Effects of tumor necrosis factor-α inhibitors on new bone formation in ankylosing spondylitis
inferred← citeshttps://doi.org/10.1016/j.jbspin.2015.08.015openalex-snapshot
Remission in axial spondyloarthritis: The ultimate treatment goal?
inferred← citeshttps://doi.org/10.1016/j.jbspin.2015.09.006openalex-snapshot
Radiographic progression in patients with ankylosing spondylitis according to tumor necrosis factor blocker exposure: Observation Study of Korean Spondyloarthropathy Registry (OSKAR) data
inferred← citeshttps://doi.org/10.1016/j.jbspin.2019.04.006openalex-snapshot
Structural progression in axial spondyloarthritis
inferred← citeshttps://doi.org/10.1016/j.jbspin.2020.105111openalex-snapshot
Long-term effect of TNF inhibitors on radiographic progression in ankylosing spondylitis is associated with time-averaged CRP levels
inferred← citeshttps://doi.org/10.1016/j.jbspin.2025.105963openalex-snapshot
Transforming myth into reality: a narrative review on the effect of therapies in slowing structural damage progression in axial spondyloarthritis
inferred← citeshttps://doi.org/10.1016/j.molimm.2013.07.016openalex-snapshot
Inflammatory pathways in spondyloarthritis
inferred← citeshttps://doi.org/10.1016/j.monrhu.2010.01.003openalex-snapshot
Imagerie dans la spondylarthrite ankylosante : critères et indices
inferred← citeshttps://doi.org/10.1016/j.monrhu.2014.07.001openalex-snapshot
Rémission et poussée dans la spondyloarthrite
inferred← citeshttps://doi.org/10.1016/j.monrhu.2014.08.001openalex-snapshot
L’enthèse : la piste pour la pathogénie des spondyloarthrites ?
inferred← citeshttps://doi.org/10.1016/j.monrhu.2015.01.005openalex-snapshot
Facteurs pronostiques dans les spondyloarthrites axiales
inferred← citeshttps://doi.org/10.1016/j.rdc.2012.04.007openalex-snapshot
Early Spondyloarthritis
inferred← citeshttps://doi.org/10.1016/j.rdc.2012.08.003openalex-snapshot
Pathophysiology of New Bone Formation and Ankylosis in Spondyloarthritis
inferred← citeshttps://doi.org/10.1016/j.rdc.2012.08.005openalex-snapshot
Therapeutic Controversies in Spondyloarthritis
inferred← citeshttps://doi.org/10.1016/j.rdc.2013.06.002openalex-snapshot
Update on Juvenile Spondyloarthritis
inferred← citeshttps://doi.org/10.1016/j.rdc.2020.01.011openalex-snapshot
Treat to Target in Axial Spondyloarthritis
inferred← citeshttps://doi.org/10.1016/j.reuma.2009.12.001openalex-snapshot
Manejo del paciente con espondiloartritis anquilosante en remisión parcial con tratamiento biológico: ¿es posible suspender el tratamiento?
inferred← citeshttps://doi.org/10.1016/j.reuma.2009.12.003openalex-snapshot
Radiografía convencional: BASRI total y SASSS
inferred← citeshttps://doi.org/10.1016/j.reuma.2010.07.001openalex-snapshot
La terapia anti-TNF en la espondilitis anquilosante (EA). ¿Es posible suspender el tratamiento?
inferred← citeshttps://doi.org/10.1016/j.reuma.2010.12.002openalex-snapshot
Documento SER de consenso sobre el uso de terapias biológicas en la espondilitis anquilosante y otras espondiloartritis, excepto la artritis psoriásica
inferred← citeshttps://doi.org/10.1016/j.reuma.2013.04.003openalex-snapshot
Ausencia de progresión radiológica a los 2 años en una cohorte de pacientes con espondiloartritis axial no radiológica tratados con terapia anti-TNF-α
inferred← citeshttps://doi.org/10.1016/j.reuma.2016.04.013openalex-snapshot
Association between serum dickkopf-1 levels and disease duration in axial spondyloarthritis
inferred← citeshttps://doi.org/10.1016/j.reuma.2017.08.008openalex-snapshot
Recomendaciones de la Sociedad Española de Reumatología sobre el uso de terapias biológicas en espondiloartritis axial
inferred← citeshttps://doi.org/10.1016/j.reumae.2013.12.014openalex-snapshot
Absence of Radiographic Progression at Two Years in a Cohort of Patients With Non-radiographic Axial Spondyloarthritis Treated With TNF-α Blockers
inferred← citeshttps://doi.org/10.1016/j.reumae.2016.04.016openalex-snapshot
Association between serum dickkopf-1 levels and disease duration in axial spondyloarthritis
inferred← citeshttps://doi.org/10.1016/j.reumae.2017.08.004openalex-snapshot
Recommendations by the Spanish Society of Rheumatology on the Use of Biological Therapies in Axial Spondyloarthritis
inferred← citeshttps://doi.org/10.1016/j.rhum.2011.11.003openalex-snapshot
Un aperçu de la physiopathologie de la spondylarthrite ankylosante : contribution des modèles animaux
inferred← citeshttps://doi.org/10.1016/j.rhum.2012.09.003openalex-snapshot
Évaluation de l’activité de la spondylarthrite par les patients et les médecins : ASDAS, BASDAI, PASS et poussée. À propos de 200 cas
inferred← citeshttps://doi.org/10.1016/j.rhum.2012.12.015openalex-snapshot
L’ossification dans les spondyloarthrites axiales
inferred← citeshttps://doi.org/10.1016/j.rhum.2015.06.004openalex-snapshot
La rémission dans la spondyloarthrite axiale : l’objectif thérapeutique ultime ?
inferred← citeshttps://doi.org/10.1016/j.rhum.2017.01.004openalex-snapshot
Effets des anti-TNFα sur la formation d’os nouveau dans la spondylarthrite ankylosante
inferred← citeshttps://doi.org/10.1016/j.rhum.2017.05.002openalex-snapshot
Progression radiographique dans la spondylarthrite ankylosante en fonction de la prise d’inhibiteurs du TNF-alpha : étude observationnelle du registre coréen des spondyloarthropathies (OSKAR)
inferred← citeshttps://doi.org/10.1016/j.rhum.2020.01.008openalex-snapshot
La progression structurale dans la spondyloarthrite axiale
inferred← citeshttps://doi.org/10.1016/j.rhum.2021.09.008openalex-snapshot
L’effet à long terme des inhibiteurs du TNF sur la progression radiographique dans la spondyloarthrite ankylosante est associé à la concentration moyenne de CRP
inferred← citeshttps://doi.org/10.1016/j.semarthrit.2015.08.005openalex-snapshot
Inflammatory and fatty lesions in the spine and sacroiliac joints on whole-body MRI in early axial spondyloarthritis—3-Year data of the ESTHER trial
inferred← citeshttps://doi.org/10.1016/j.semarthrit.2025.152888openalex-snapshot
Factors associated with rapid spinal radiographic progression in patients with axial spondyloarthritis: A hospital-based retrospective cohort study with mSASSS scoring using deep learning model
inferred← citeshttps://doi.org/10.1016/s0121-8123(12)70035-xopenalex-snapshot
Los anti-TNF y la progresión radiográfica en espondilitis anquilosante
inferred← citeshttps://doi.org/10.1016/s0140-6736(11)60071-8openalex-snapshot
Spondyloarthritis
inferred← citeshttps://doi.org/10.1016/s0140-6736(11)61119-7openalex-snapshot
A strategic revolution in HIV and global health
inferred← citeshttps://doi.org/10.1016/s2173-5743(10)70055-1openalex-snapshot
Anti-TNF therapy in Ankylosing Spondylitis (AS). Is it possible to suspend treatment?
inferred← citeshttps://doi.org/10.1016/s2173-5743(11)70022-3openalex-snapshot
Consensus Statement of the Spanish Society of Rheumatology on the management of biologic therapies in Spondyloarthritis except for Psoriatic Arthritis
inferred← citeshttps://doi.org/10.1021/acsnano.3c09480openalex-snapshot
Tetrahedral Framework Nuclear Acids Can Regulate Interleukin-17 Pathway to Alleviate Inflammation and Inhibit Heterotopic Ossification in Ankylosing Spondylitis
inferred← citeshttps://doi.org/10.1038/nm.2817openalex-snapshot
IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4−CD8− entheseal resident T cells
inferred← citeshttps://doi.org/10.1038/nrrheum.2009.205openalex-snapshot
Pharma news: Adalimumab for AS
inferred← citeshttps://doi.org/10.1038/nrrheum.2010.79openalex-snapshot
Pathogenesis of ankylosing spondylitis
inferred← citeshttps://doi.org/10.1038/nrrheum.2011.156openalex-snapshot
The balance of tissue repair and remodeling in chronic arthritis
inferred← citeshttps://doi.org/10.1038/nrrheum.2012.40openalex-snapshot
Developments in therapies for spondyloarthritis
inferred← citeshttps://doi.org/10.1038/nrrheum.2013.123openalex-snapshot
Treat-to-target in spondyloarthritis—do we have a plan?
inferred← citeshttps://doi.org/10.1038/nrrheum.2013.83openalex-snapshot
Opinion: Perspectives on imaging in axial spondyloarthritis
inferred← citeshttps://doi.org/10.1038/nrrheum.2016.42openalex-snapshot
New evidence on the management of spondyloarthritis
inferred← citeshttps://doi.org/10.1038/nrrheum.2017.197openalex-snapshot
TNF inhibitors and structural damage in ankylosing spondylitis
inferred← citeshttps://doi.org/10.1038/s41584-022-00761-zopenalex-snapshot
Treatment of axial spondyloarthritis: an update
inferred← citeshttps://doi.org/10.1038/s41598-019-54549-5openalex-snapshot
Effect of tumor necrosis factor inhibition on spinal inflammation and spinal ankylosis in SKG mice
inferred← citeshttps://doi.org/10.1038/srep32202openalex-snapshot
TNF-α Promoter Polymorphisms Predict the Response to Etanercept More Powerfully than that to Infliximab/Adalimumab in Spondyloarthritis
inferred← citeshttps://doi.org/10.1038/srep34643openalex-snapshot
Inhibition of Complement Retards Ankylosing Spondylitis Progression
inferred← citeshttps://doi.org/10.1055/a-0994-9786openalex-snapshot
Ist eine Hemmung der röntgenologischen Progression bei axialer Spondyloarthritis möglich?
inferred← citeshttps://doi.org/10.1080/03009742.2018.1506822openalex-snapshot
Structural progression rate decreases over time on serial radiography and magnetic resonance imaging of sacroiliac joints and spine in a five-year follow-up study of patients with ankylosing spondylitis treated with tumour necrosis factor inhibitor
inferred← citeshttps://doi.org/10.1080/07853890.2016.1243802openalex-snapshot
Pathogenesis of ligaments ossification in spondyloarthritis: insights and doubts
inferred← citeshttps://doi.org/10.1080/13543784.2021.2010187openalex-snapshot
Disease modification in ankylosing spondylitis with TNF inhibitors: spotlight on early phase clinical trials
inferred← citeshttps://doi.org/10.1080/14397595.2017.1367076openalex-snapshot
Prevalence of Ankylosing Spondylitis Disease Activity Score (ASDAS) inactive disease in a cohort of patients treated with TNF-alpha inhibitors
inferred← citeshttps://doi.org/10.1080/14397595.2018.1525017openalex-snapshot
Effect of anti-tumor necrosis factor α treatment on radiographic progression in patient with ankylosing spondylitis: A systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1080/14397595.2018.1525024openalex-snapshot
Real-world effectiveness and safety of adalimumab for treatment of ankylosing spondylitis in Japan
inferred← citeshttps://doi.org/10.1080/14656566.2019.1617853openalex-snapshot
Pharmacological management of axial spondyloarthritis in adults
inferred← citeshttps://doi.org/10.1080/14712598.2017.1256387openalex-snapshot
Golimumab for the treatment of axial spondyloarthritis
inferred← citeshttps://doi.org/10.1080/14712598.2024.2389987openalex-snapshot
The management of axial spondyloarthritis with cutting-edge therapies: advancements and innovations
inferred← citeshttps://doi.org/10.1080/14728214.2018.1445719openalex-snapshot
Emerging drugs for the treatment of axial spondyloarthritis
inferred← citeshttps://doi.org/10.1080/1744666x.2018.1476849openalex-snapshot
The role of imaging in early diagnosis and prevention of joint damage in inflammatory arthritis
inferred← citeshttps://doi.org/10.1080/21678707.2018.1433032openalex-snapshot
Tumour necrosis factor inhibitors in enthesitis related arthritis and juvenile spondylarthropathies
inferred← citeshttps://doi.org/10.1093/ibd/izy339openalex-snapshot
The Prevalence and Clinical Associations of Subclinical Sacroiliitis in Inflammatory Bowel Disease
inferred← citeshttps://doi.org/10.1093/rheumatology/keaa296openalex-snapshot
Changes in bone formation regulator biomarkers in early axial spondyloarthritis
inferred← citeshttps://doi.org/10.1093/rheumatology/keab841openalex-snapshot
Certolizumab pegol treatment in axial spondyloarthritis mitigates fat lesion development: 4-year post-hoc MRI results from a phase 3 study
inferred← citeshttps://doi.org/10.1093/rheumatology/ker194openalex-snapshot
Persistent clinical efficacy and safety of infliximab in ankylosing spondylitis after 8 years--early clinical response predicts long-term outcome
inferred← citeshttps://doi.org/10.1093/rheumatology/kes364openalex-snapshot
The paradoxical effects of TNF inhibitors on bone mineral density and radiographic progression in patients with ankylosing spondylitis
inferred← citeshttps://doi.org/10.1093/rheumatology/ket407openalex-snapshot
Spondyloarthritis: from unifying concepts to improved treatment
inferred← citeshttps://doi.org/10.1093/rheumatology/keu438openalex-snapshot
Maintenance of improvement in spinal mobility, physical function and quality of life in patients with ankylosing spondylitis after 5 years in a clinical trial of adalimumab
inferred← citeshttps://doi.org/10.1093/rheumatology/kex321openalex-snapshot
Limited reliability of radiographic assessment of spinal progression in ankylosing spondylitis
inferred← citeshttps://doi.org/10.1093/rheumatology/kex448openalex-snapshot
Bone formation in ankylosing spondylitis during anti-tumour necrosis factor therapy imaged by 18F-fluoride positron emission tomography
inferred← citeshttps://doi.org/10.1093/rheumatology/key034openalex-snapshot
Bone formation in ankylosing spondylitis during anti-tumour necrosis factor therapy imaged by 18F-fluoride positron emission tomography
inferred← citeshttps://doi.org/10.1093/rheumatology/key128openalex-snapshot
Modified stoke ankylosing spondylitis spinal score as an outcome measure to assess the impact of treatment on structural progression in ankylosing spondylitis
inferred← citeshttps://doi.org/10.1093/rheumatology/key217openalex-snapshot
The current standard of care and the unmet needs for axial spondyloarthritis
inferred← citeshttps://doi.org/10.1093/rheumatology/key375openalex-snapshot
Secukinumab shows sustained efficacy and low structural progression in ankylosing spondylitis: 4-year results from the MEASURE 1 study
inferred← citeshttps://doi.org/10.1093/rheumatology/kez363openalex-snapshot
The effect of tumour necrosis factor inhibitors on radiographic progression in axial spondyloarthritis: a systematic literature review
inferred← citeshttps://doi.org/10.1097/bor.0000000000000025openalex-snapshot
Measurement and treatment of radiographic progression in ankylosing spondylitis
inferred← citeshttps://doi.org/10.1097/bor.0000000000000053openalex-snapshot
Clinical studies on bone-related outcome and the effect of TNF-α blocking therapy in ankylosing spondylitis
inferred← citeshttps://doi.org/10.1097/bor.0000000000000404openalex-snapshot
Mechanisms, impact and prevention of pathological bone regeneration in spondyloarthritis
inferred← citeshttps://doi.org/10.1097/bor.0000000000001025openalex-snapshot
Disease modification in axial spondyloarthritis – still a controversy?
inferred← citeshttps://doi.org/10.1097/bor.0b013e32833aaf93openalex-snapshot
Editorial review: how early should ankylosing spondylitis be treated with a tumor necrosis factor-blocker?
showing the first 200 of 398 · page through all 398
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.